HI Form 4: Megan Walke Sells 4,966 Shares; 46 Restricted Shares Vest

Rhea-AI Filing Summary

Megan A. Walke, listed as Interim CFO, VP, CC & CAO of Hillenbrand, Inc. (HI), reported transactions dated 09/30/2025. The filing shows a disposition of 4,966 shares of common stock and the vesting/acquisition of restricted stock units from three deferred awards: 4 units (award dated 12/7/2022), 15 units (award dated 12/7/2023), and 27 units (award dated 12/5/2024), each representing a contingent right to one share. The RSUs carry dividend equivalent rights and have scheduled vesting in one‑third installments across the specified multi‑year schedules. The form is signed by an attorney‑in‑fact, Allison A. Westfall, dated 10/02/2025.

Positive

• Acquisition of 46 RSUs (4+15+27) from deferred awards, each convertible to one share
• RSUs include dividend equivalent rights, preserving economic alignment until share delivery

Negative

• Disposition of 4,966 common shares on 09/30/2025, reducing direct holdings
• Significant remaining vesting schedules indicate future dilution timing (one‑third vesting tranches)

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

WALKE MEGAN A

(Last) (First) (Middle)

ONE BATESVILLE BOULEVARD

(Street)

BATESVILLE IN 47006

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hillenbrand, Inc. [ HI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Interim CFO, VP, CC, & CAO

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								4,966	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units (Deferred Stock Award 12/7/2022)	(1)	09/30/2025		A(2)		4		(3)	(3)	Common Stock	4	$0	574	D
Restricted Stock Units (Deferred Stock Award 12/7/2023)	(1)	09/30/2025		A(2)		15		(4)	(4)	Common Stock	15	$0	1,828	D
Restricted Stock Units (Deferred Stock Award 12/5/2024)	(1)	09/30/2025		A(2)		27		(5)	(5)	Common Stock	27	$0	3,369	D

Explanation of Responses:

1. Each Restricted Stock Unit represents the contingent right to receive one share of the issuer's common stock.

2. Restricted Stock Units are entitled to dividend equivalent rights which accrue on dividend record dates.

3. Restricted Stock Units scheduled to vest one-third on 12/7/2023, one-third on 12/7/2024, and one-third on 12/7/2025.

4. Restricted Stock units scheduled to vest one-third on 12/7/2024, one-third on 12/7/2025, and one-third on 12/7/2026.

5. Restricted Stock units scheduled to vest one-third on 12/5/2025, one-third on 12/5/2026, and one-third on 12/5/2027.

Remarks:

	/s/ Allison A. Westfall, Attorney-in-fact for Megan A. Walke	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who filed this Form 4 for Hillenbrand (HI)?

The filing reports transactions by Megan A. Walke, identified as Interim CFO, VP, CC & CAO.

What transactions were reported on 09/30/2025?

A reported disposition of 4,966 shares of common stock and the acquisition/vesting of 4, 15, and 27 restricted stock units from deferred awards.

What do the Restricted Stock Units represent?

Each RSU represents the contingent right to receive one share of Hillenbrand common stock and carries dividend equivalent rights.

How do the RSU vesting schedules work?

The RSUs vest in one‑third installments across the specified years (examples: 12/7/2023–2025; 12/7/2024–2026; 12/5/2025–2027 as noted).

Who signed the Form 4 and when?

The form is signed by Allison A. Westfall, Attorney‑in‑fact, on 10/02/2025.